Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

PIZENSY

LACTITOL

Standard Dose
10GM
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview PIZENSY is listed in Drugs@FDA under application 211281 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient LACTITOL Form and strength FOR SOLUTION;ORAL - 10GM Sponsor BRAINTREE LABS Submission history Latest submission status date: 2021-08-17 00:00:00.

Structured Monograph

Clinical summary

Approval overview PIZENSY is listed in Drugs@FDA under application 211281 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient LACTITOL Form and strength FOR SOLUTION;ORAL - 10GM Sponsor BRAINTREE LABS Submission history Latest submission status date: 2021-08-17 00:00:00. Submission type: SUPPL.

Monitoring

  • Marketing status: Discontinued
  • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
PIZENSY (LACTITOL) | Drug Monograph | MedicHelpline